Italy· 045214020
CANDETENS
A candesartan und amlodipin product containing candesartan cilexetil + amlodipina, registered in Italy by SCHARPER S.P.A., on the national reimbursement list. The same ATC class is registered in 6 of our 19 countries.
Checked against AIFA (Italy) on
Informational only — not a medical device.
Where it is registered
Candesartan und amlodipin is registered in 6 of 19 countries.
Countries holding a registration under ATC C09DB07 (candesartan und amlodipin), each read from that country’s own register.
- This record: Italy, from AIFA (Italy)
- 6 of them publish a price we can compare per daily dose
Candesartan und amlodipin · ATC C09DB07
6 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Italyprice
- Polandprice
- Switzerlandprice
The record
At a glance
AIFA (Italy)- Active substance
- Candesartan cilexetil + Amlodipina
- Manufacturer
- SCHARPER S.P.A.
- Country
- Italy (IT)
- ATC code
- C09DB07
- ATC class
- Candesartan und Amlodipin
- Reimbursed
- Yes
- Source register
- AIFA (Italy)
- Last checked
- September 28, 2026
Packs & prices · 1
1 priced- aic045214020"16 MG + 5 MG CAPSULE RIGIDE" 28 CAPSULE IN BLISTER PA/AL/PVC/ALEUR 8.94
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
8 interactions on record for candesartan und amlodipin.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Candesartan und amlodipin · interactions on record
8 records
8 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Candesartan und amlodipin in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBILAMCARSwyssi AG, Frankfurt am Main
- GermanyCamlostarAristo Pharma Gmbh (Art 57)
- FinlandAltensilLusomedicamenta Sociedade Técnica Farmacêutica SA
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Candam, Candeblo Amlo
- Belgium · Candesartan/Amlodipine Krka
- Bulgaria · Bilamcar 16 Mg/10, Bilamcar 8 Mg/10 Mg
- Czechia · Bilamcar, Camdero
- Germany · Camlostar, Candeamlo
- Estonia · Camdero, Zenicamo
- Spain · Kandoset
- Finland · Candecam
- France · Ikpara
- United Kingdom (Northern Ireland) · Candesartan Cilexetil/Amlodipine Zentiva
- Greece · Bilamcar, Caramlo
- Hungary · Kandoset
- Latvia · Camlocor, Zenicamo
- Malta · Clodipan
- Poland · Camlocor, Candezek Combi
- Portugal · Altensil, Amlodipina + Candesartan Krka
- Romania · Caramlo, Kandoset
- Slovenia · Amcandin, Camlocor
- Slovakia · Bilamcar 16 Mg/10 Mg, Bilamcar 16 Mg/5 Mg
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AIFA (Italy). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a9db60b2-a199-434d-970c-4abd0aaaf169 GET /v1/drugs/a9db60b2-a199-434d-970c-4abd0aaaf169?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pack": "\"16 MG + 5 MG CAPSULE RIGIDE\" 28 CAPSULE IN BLISTER PA/AL/PVC/AL",
"source": "aifa",
"currency": "EUR",
"substance": "Candesartan cilexetil + Amlodipina",
"reference_pack": "28 UNITA' (16+5) MG - USO ORALE",
"public_price_eur": 8.94,
"ssn_reference_price_eur": 8.94
}See everything about candesartan und amlodipin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.